Healthtech Series A Investors & VC Firms
2210 firms in this list, with a median first check of $500K. 526 of them lead rounds. Generated from verified public data and updated continuously.
WELL Ventures
VancouverSeed–Growth
16 people
SCI Ventures
LondonSeed–Series B
18 people
Sonder Capital
San CarlosPre-Seed–Late Stage
15 people
SyndicateRoom
CambridgePre-Seed–Series A
15 people
LYFE Capital
Menlo ParkSeed–Late Stage
17 people
Betatron Venture Group
Hong KongPre-Seed–Series A$30K – $2M
7 people
MGV Capital
San AntonioPre-Seed–Series A$250K – $1M
10 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
VestedWorld
ChicagoSeed–Late Stage$500K – $1M
7 people
Danone Manifesto Venture
New York CitySeed–Growth
11 people
Eos Venture Partners Limited
LondonSeries A$7M – $10M
11 people
Eka Ventures
LondonPre-Seed–Series A$635K – $3.8M
7 people
Wittington Ventures
TorontoSeed–Late Stage
13 people
Brightlands Venture Partners
GeleenSeed–Series B$540K – $2.2M
15 people
CTI Life Sciences Fund L.P.
MontréalSeed–Late Stage
9 people
Impact America Fund
IrvineSeed–Series B$250K – $3M
9 people
OWW Capital Partners Pte. Ltd.
SingaporeSeed–Late Stage$500K – $10M
9 people
Puhua Capital
HangzhouPre-Seed–Late Stage$1.4M – $112M
White Fund
LiègeSeed–Series B$2.2M – $5.4M
15 people
Cowin Capital Group
ShenzhenSeed–Late Stage$1.4M – $50M
11 people
Pathway to Cures
New YorkSeed–Series A
20 people
Time BioVentures
Southern CaliforniaSeed–Series A
17 people
Triventures
HerzliyaPre-Seed–Series A$1M – $3M
11 people
Artisanal Ventures
TiburonSeed–Series A
7 people
Related lists
Series A Investors & VC Firms (7875)Series A Investors & VC Firms in United States (3337)Healthtech Investors & VC Firms (3208)SaaS Series A Investors & VC Firms (2667)Healthtech Seed Investors & VC Firms (2488)AI & Machine Learning Series A Investors & VC Firms (2343)Enterprise Software Series A Investors & VC Firms (2324)Fintech Series A Investors & VC Firms (2239)Series A Investors & VC Firms in Global (2163)Consumer Series A Investors & VC Firms (1652)
Data sourced from public filings and firms' own websites — see our methodology.





































































